Elevance Health Inc. (ELV) Earnings History
Annual and quarterly earnings data from 2001 to 2025
Loading earnings history...
EPS Growth Rates (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 56.2% | 3.5% | 2.8% |
| 2024 | 100.0% | 4.5% | 3.4% |
| 2023 | 100.0% | 4.5% | 3.5% |
| 2022 | 100.0% | 4.9% | 3.8% |
| 2021 | 100.0% | 5.8% | 4.4% |
Download Data
Export ELV earnings history in CSV or JSON format
Free sign-in required to download data
Elevance Health Inc. (ELV) Earnings Overview
As of February 28, 2026, Elevance Health Inc. (ELV) reported trailing twelve-month net income of $5.66B, reflecting -0.0% year-over-year growth. The company earned $25.53 per diluted share over the past four quarters, with a net profit margin of 0.0%.
Looking at the long-term picture, ELV's 5-year EPS compound annual growth rate (CAGR) stands at +6.9%, showing solid earnings momentum. The company achieved its highest annual net income of $6.16B in fiscal 2021.
Elevance Health Inc. maintains positive profitability with a gross margin of 0.6%, operating margin of 0.0%, and net margin of 0.0%. The company continues to generate positive earnings from operations. View revenue history →
Compared to industry peers including HUM ($1.29B net income, 0.0% margin), ELV has outperformed on profitability metrics. Compare ELV vs HUM →
Peer Comparison
Earnings metrics vs industry competitors
| Company | TTM Net Income | TTM EPS | Net Margin | ROE | YoY Growth | Compare |
|---|---|---|---|---|---|---|
ELVCurrent | $5.7B | $25.53 | 0.0% | 0.1% | -0.0% | — |
HUM | $1.3B | $10.69 | 0.0% | 0.1% | -0.5% |
Historical Data
25 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $5.66B | -5.3% | $6.99B | $25.12 | 2.8% | 3.5% |
| 2024 | $5.98B | -0.1% | $7.90B | $25.68 | 3.4% | 4.5% |
| 2023 | $5.99B | +1.6% | $7.71B | $25.22 | 3.5% | 4.5% |
| 2022 | $5.89B | -4.3% | $7.60B | $24.28 | 3.8% | 4.9% |
| 2021 | $6.16B | +34.7% | $8.00B | $24.73 | 4.4% | 5.8% |
| 2020 | $4.57B | -4.9% | $6.24B | $17.98 | 3.8% | 5.1% |
| 2019 | $4.81B | +28.2% | $5.99B | $18.47 | 4.6% | 5.7% |
| 2018 | $3.75B | -2.4% | $5.07B | $14.19 | 4.1% | 5.5% |
| 2017 | $3.84B | +55.6% | $3.96B | $14.35 | 4.3% | 4.4% |
| 2016 | $2.47B | -3.5% | $4.55B | $9.21 | 2.9% | 5.4% |
See ELV's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ELV Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare ELV vs AGIO
See how ELV stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is ELV growing earnings?
ELV TTM EPS: $25.53. Net income: $5.7B. Earnings growth: -0.0%.
What are ELV's profit margins?
Elevance Health Inc. net margin is +0.0%, with operating margin at +0.0%. Below-average margins reflect competitive or cost pressures.
How consistent are ELV's earnings?
ELV earnings data spans 2001-2025. The current earnings trend is -0.0% YoY. Historical data enables comparison across business cycles.